Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125 | 7,943 | 1,832 | 37 | N/A |
| Other current assets | 0 | 0 | 0 | 627 | 0 |
| TOTAL | $390 | $8,185 | $1,972 | $768 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 2 | 4 | N/A |
| TOTAL | $2 | $3 | $2 | $4 | $N/A |
| Total Assets | $392 | $8,188 | $1,974 | $772 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,202 | 4,170 | 1,522 | 855 | 0 |
| Other current liabilities | 253 | N/A | N/A | N/A | N/A |
| TOTAL | $7,454 | $4,170 | $3,805 | $855 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 105 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,454 | $4,170 | $3,805 | $855 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,584 | 21,094 | 15,728 | N/A | N/A |
| Common Shares | 21 | 21 | 15 | 13 | N/A |
| Retained earnings | -53,065 | -41,455 | -14,502 | -3,639 | N/A |
| Other shareholders' equity | -537 | -87 | -1,568 | -34 | 0 |
| TOTAL | $-7,062 | $4,017 | $-1,831 | $-83 | $N/A |
| Total Liabilities And Equity | $392 | $8,188 | $1,974 | $772 | $0 |